LAB — Standard Biotools Inc · rev $85.3M

Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.

Latest reported LAB revenue for 2025-12-31 was $85.3M. Net income was -$74.9M. LAB currently screens at market cap $317.1M.

Use this LAB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LAB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LAB SEC filings page. Lician reads the product cache first so this HTML stays unique to Standard Biotools Inc even when a live quote feed is slow.

Standard Biotools Inc latest statements (FY2025)

Latest cached year on this hub. Full LAB income, balance, and cash tables.

  • Revenue$85.3M
  • Net Income-$74.9M
  • Total Assets$567.8M
  • Total Debt$0
  • Free Cash Flow-$82.6M

LAB recent filings